Integrating Depression Services Into DM Management

Completed · Not applicable

Conditions studied: Type 2 Diabetes Mellitus, Depression

In brief

The goal of this proposal is to integrate depression services into improving adherence for oral hypoglycemic agents so that a single program can assist patients. The investigators hypothesized that patients in the intervention would demonstrate improved adherence to patients' oral hypoglycemic agents and antidepressants as well as improved clinical outcomes.

Key facts

Study ID

NCT01098253

Run by

University of Pennsylvania

People needed

182

Starts

2009-01-01

Expected to finish

2011-04-01

Last updated by the study team

2012-03-09

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 30 years and older
• a current diagnosis of Type 2 DM
• current prescription for an oral hypoglycemic agent
• current prescription for an antidepressant
• able to communicate in English
• willing to give informed consent.

You may not qualify if…

• inability to give informed consent
• significant cognitive impairment at baseline (Mini-Mental State Examination (MMSE) <21)
• residence in a care facility that provides medications
• unwillingness or inability to use the Medication Event Monitoring System

Where it is running

• University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.